Skip to main content
Clinical Trials/TCTR20230705004
TCTR20230705004Not yet recruitingPhase 2

A project to develop the supporting system for scaling up the Personalized Intensive Lifestyle Modification/coaching Program

Thai Health Promotion Foundation0 sites100 target enrollmentStarted: July 5, 2023Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 70 Years (—)
Sex
All

Inclusion Criteria

  • 1. adults aged 18-70 years old
  • 2. meet at least one of the International Diabetes Federation (IDF) criteria for metabolic syndrome including
  • 2.1 Central obesity (waist circumference 90 cm or higher in men and 80 cm or higher in women in Asian population)
  • 2.2 Elevated triglycerides 150 milligrams per deciliter of blood (mg/dL) or greater (drug treatment for elevated triglycerides is an alternate indicator)
  • 2.3 Reduced high-density lipoprotein cholesterol (HDL) less than 40 mg/dL in men or less than 50 mg/dL in women (drug treatment for reduced HDL-C is an alternate indicator)
  • 2.4 Elevated fasting plasma glucose of l00 mg/dL or greater (drug treatment of elevated glucose is an alternate indicator)
  • 2.5 Blood pressure values of systolic 130 mmHg or higher and/or diastolic 85 mmHg or higher (antihypertensive drug treatment in a patient with a history of hypertension is an alternate indicator)

Exclusion Criteria

  • 1. Having a health condition that prohibits exercise, such as being recently diagnosed with ischemic heart disease or having had a stroke within the past month, having excessively low or high blood pressure, or experiencing uncontrolled arrhythmia or a recent heart attack.
  • 2. Unable to be monitored or tracked for a period of 12 months.

Investigators

Similar Trials